Decibel’s looking for therapies that can treat hearing loss. The aim is that, instead of using a device to hear, one day you might be able to take a medication.
Decibel Therapeutics, a company that’s researching treatments for hearing loss, has struck up a somewhat unusual partnership with biotech giant Regeneron.
Instead of a deal that gives the larger company development and commercialization rights over a particular drug, this collaboration is aimed at giving Decibel access to Regeneron’s scientific expertise.
Decibel Therapeutics, a small startup that’s looking for treatments for hearing loss, just landed an unconventional endorsement from Regeneron.
Typically, partnerships between big pharma companies and small startups are formed to fill a gap in product pipeline or to give the bigger company access to technology it has the muscle to develop.
That’s not the case here, Decibel CEO Steve Holtzman told Business Insider.
Tech: A startup searching for a drug to treat hearing loss just got an unusual endorsement from a big biotech
